Singapore, Dec. 4 -- Leading European biopharmaceutical company, Menarini Asia-Pacific, has announced the expansion of its export manufacturing hub, PT. Menarini Indria Laboratories (Milab), in Cikarang, West Java, Indonesia.This strategic milestone positions Menarini to meet growing regional demand while elevating Indonesia's role in the pharmaceutical supply chain.

With support from the Indonesian government, Milab has achieved remarkable growth. From 2023 to 2025, its total export volume for Dermatix as well as other oral solid and oral liquid pharmaceutical products more than doubled, reaching a projected cumulative total of 2.8 million units by 2025. This growth is driven by significant investments in advanced infrastructure and tec...